BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PitchBoulder - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PitchBoulder
X-ORIGINAL-URL:https://pitchboulder.co
X-WR-CALDESC:Events for PitchBoulder
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Denver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20260308T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20261101T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20270314T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20271107T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Denver:20260225T083000
DTEND;TZID=America/Denver:20260225T103000
DTSTAMP:20260430T212100
CREATED:20260217T164639Z
LAST-MODIFIED:20260225T184554Z
UID:6880-1772008200-1772015400@pitchboulder.co
SUMMARY:Presenting: NeuroGeneces – Measure Brain Health Before Decline
DESCRIPTION:NeuroGeneces (https://neurogeneces.com/) — Co-Founder Karen Crow presenting — is a brain health diagnostics company developing an at-home functional Brain Age assessment to detect cognitive decline before symptoms appear. \nCognitive decline is the top health concern among midlife adults\, yet most neurodegeneration is only detected after symptoms emerge—when intervention options are limited. While up to 45% of dementia cases may be preventable through lifestyle change\, current tools measure structure or biomarkers but fail to assess how well the brain is actually functioning. NeuroInsight\, their flagship product\, uses sleep EEG to measure functional Brain Age by analyzing over 400 validated neurophysiological biomarkers with AI. Results are compared to a large normative database to determine whether the brain is aging normally\, accelerated\, or unusually resilient. By linking Brain Age to modifiable lifestyle factors\, NeuroInsight transforms measurement into actionable prevention. \nOur target market is prevention-focused adults and concierge/primary care practices in the U.S. who need a functional\, early indicator of brain health and are willing to pay for proactive\, data-driven prevention tools. \nOur competition is blood-based biomarkers\, brain imaging diagnostics\, and consumer cognitive testing platforms. Our competitive advantage is a functional measure of brain performance during sleep\, patented EEG analysis\, AI-driven biomarker modeling\, and a prevention-first positioning. \nThe total market size in 2024 is the U.S. brain health and cognitive diagnostics market\, and the total market revenue in 2024 is $10B+. \nTop 3 challenges: \n\nDeveloping effective marketing and sales resources for clinicians\nBuilding a strong pipeline of concierge and prevention-focused providers\nSeamless integration into physician workflow and care models\n\nOur PitchBoulder ask: We’re looking for candid feedback on the biggest business risks or gaps our pitch deck may not address. What would you need to see to consider this investable? We also welcome introductions to concierge primary care\, direct primary care\, and longevity clinics aligned with proactive brain health.
URL:https://pitchboulder.co/event/presenting-neurogeneces-measure-brain-health-before-decline/
LOCATION:Galvanize Boulder\, 1023 Walnut St.\, Boulder\, CO\, 80302\, US
ATTACH;FMTTYPE=image/jpeg:https://pitchboulder.co/wp-content/uploads/2026/02/6880_image_highres_532788721.jpeg
ORGANIZER;CN="PitchBoulder":MAILTO:PitchBoulder-announce@messages.meetup.com
END:VEVENT
END:VCALENDAR